These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 38239356)

  • 61. Nanomaterials in combating cancer: therapeutic applications and developments.
    Nazir S; Hussain T; Ayub A; Rashid U; MacRobert AJ
    Nanomedicine; 2014 Jan; 10(1):19-34. PubMed ID: 23871761
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy.
    Wei W; Rosenkrans ZT; Luo QY; Lan X; Cai W
    Small Methods; 2019 Feb; 3(2):. PubMed ID: 31355327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hybrid carbon-based materials for gene delivery in cancer therapy.
    Taghavi S; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    J Control Release; 2020 Feb; 318():158-175. PubMed ID: 31862358
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
    Muthu MS; Leong DT; Mei L; Feng SS
    Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel Tumor-Targeting Nanoparticles for Cancer Treatment-A Review.
    Niculescu AG; Grumezescu AM
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563645
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Self-assembling Peptides in Current Nanomedicine: Versatile Nanomaterials for Drug Delivery.
    Peng F; Zhang W; Qiu F
    Curr Med Chem; 2020; 27(29):4855-4881. PubMed ID: 31309877
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of Nanomaterials in Autophagy.
    Wei M; Le WD
    Adv Exp Med Biol; 2019; 1206():273-286. PubMed ID: 31776991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.
    Su X; Zhang X; Liu W; Yang X; An N; Yang F; Sun J; Xing Y; Shang H
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):929-942. PubMed ID: 34375726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nanomaterials for oncotherapies targeting the hallmarks of cancer.
    Dai X; Yu L; Zhao X; Ostrikov KK
    Nanotechnology; 2020 Sep; 31(39):392001. PubMed ID: 32503023
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent Advances of Gold Nanoparticles in Biomedical Applications: State of the Art.
    Aminabad NS; Farshbaf M; Akbarzadeh A
    Cell Biochem Biophys; 2019 Jun; 77(2):123-137. PubMed ID: 30570696
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nanomaterial-mediated autophagy: coexisting hazard and health benefits in biomedicine.
    Feng X; Zhang Y; Zhang C; Lai X; Zhang Y; Wu J; Hu C; Shao L
    Part Fibre Toxicol; 2020 Oct; 17(1):53. PubMed ID: 33066795
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interlocked systems in nanomedicine.
    Ornelas-Megiatto C; Becher TB; Megiatto JD
    Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nanomedicine: application areas and development prospects.
    Boulaiz H; Alvarez PJ; Ramirez A; Marchal JA; Prados J; Rodríguez-Serrano F; Perán M; Melguizo C; Aranega A
    Int J Mol Sci; 2011; 12(5):3303-21. PubMed ID: 21686186
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nanoparticles containing insoluble drug for cancer therapy.
    Guo S; Huang L
    Biotechnol Adv; 2014; 32(4):778-88. PubMed ID: 24113214
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
    Jain V; Jain S; Mahajan SC
    Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine.
    Sun R; Dai J; Ling M; Yu L; Yu Z; Tang L
    J Nanobiotechnology; 2022 Apr; 20(1):194. PubMed ID: 35443712
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cholesterol Modified Self-Assemblies and Their Application to Nanomedicine.
    Ercole F; Whittaker MR; Quinn JF; Davis TP
    Biomacromolecules; 2015 Jul; 16(7):1886-914. PubMed ID: 26098044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.